5 февр. 2024 г. · Catalent and Novo Holdings have entered into a merger agreement in an all-cash transaction that values Catalent at $16.5 billion.

3 нояб. 2024 г. · Catalent was recently acquired by Novo Holdings for $16.5 billion. This deal is slated to close later in 2024. As part of the deal, Novo Nordisk ...

4 нояб. 2024 г. · EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent (CTLT.N).

23 окт. 2024 г. · While Novo Holdings and Catalent continue to voice confidence that their planned $16.5 billion merger will go through before the year is out ...

21 окт. 2024 г. · Catalent's acquisition by Novo Holdings is expected to close towards the end of calendar year 2024, subject to customary closing conditions.

Catalent has entered into an agreement to be acquired by Novo Holdings, a global investment firm focused on life sciences.

30 окт. 2024 г. · The deal would help the Danish drugmaker secure manufacturing capabilities for its popular weight loss and diabetes drugs Ozempic and Wegovy.

24 окт. 2024 г. · Novo Holdings announced the $16.5 billion acquisition of Catalent, a deal that would ultimately see Novo Nordisk taking manufacturing sites for $11 billion.

10 окт. 2024 г. · Novo Holdings' proposed Catalent acquisition is facing a fresh round of lawmaker scrutiny as the U.S. FTC has yet to reach a decision.

7 дней назад · The Trump administration's Department of Justice brought the first vertical merger challenge in federal district court in roughly 40 years when ...